BI Asset Management Fondsmaeglerselskab’s Dr. Reddy's Laboratories RDY Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-84,493	Closed	-$1.33M	–	947
2024 Q4	$1.33M	Sell	84,493 -6,832	-7%	-$103K	0.01%	445
2024 Q3	$1.45M	Buy	91,325 +60,240	+194%	+$969K	0.03%	325
2024 Q2	$474K	Sell	31,085 -5,500	-15%	-$78.8K	0.01%	507
2024 Q1	$537K	Buy	+36,585	New	+$534K	0.01%	510
2023 Q4	–	Sell	-8,065	Closed	-$108K	–	776
2023 Q3	$108K	Buy	+8,065	New	+$109K	﹤0.01%	670

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's RDY Position: Q1 2025 in Review

BI Asset Management Fondsmaeglerselskab sold out of Dr. Reddy's Laboratories (RDY) in Q1 2025, closing a stake of 84,493 shares — an estimated $1.33M sold.

BI Asset Management Fondsmaeglerselskab first reported a position in RDY in Q3 2023 and held it in 5 quarters. The position peaked at $1.45M in Q3 2024. 245 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

BI Asset Management Fondsmaeglerselskab reported no remaining Dr. Reddy's Laboratories position as of Q1 2025 after selling out during the quarter.
BI Asset Management Fondsmaeglerselskab sold 84,493 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $1.33M.
BI Asset Management Fondsmaeglerselskab first reported a position in Dr. Reddy's Laboratories in Q3 2023 and held it in 5 quarters.
BI Asset Management Fondsmaeglerselskab's Dr. Reddy's Laboratories position peaked at $1.45M in Q3 2024.
245 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q1 2025, filed 14 May 2025.